Crystal modification of a N-phenyl-2-pyrimidineamine...

Details Crystal modification of a N-phenyl-2-pyrimidineamine... Crystal modification of a N-phenyl-2-pyrimidineamine...

2005-05-17

2005-05-17

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S295000

Reexamination Certificate

active

06894051

ABSTRACT:
The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide of formula 1, which may be used for example for tumor therapy.

REFERENCES:
patent: 4351832 (1982-09-01), Rakhit et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5985893 (1999-11-01), Yu et al.
patent: 6048866 (2000-04-01), Hutchings et al.
patent: WO 8500604 (1985-02-01), None
Zimmermann, et al., Potent and Selective Inhibitors of the Abl-Kinase: Phenylaminopyrimidine (PAP) Derivatives, Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 2, pp. 187-192 (1997).
Elisabeth Buchdunger, et al., Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivatives, Cancer Research, pp. 100-104, Jan. 1, 1996.
Byrn, Stephen et al., “Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations, ” Pharmaceutical Research, vol. 12, No. 7, pp. 945-954 (1995).
Davey, R.J. et al., “Polymorphism in Molecular Crystals: Stabilization of a Metastable Form by Confirmation Mimicry, ” J. Am. Chem. Soc. 1997, vol. 119, pp. 1767-1772 (1997).
Hollis Showalter H.D. et al., “Small Molecule Inhibitors of the Platelet-Derived Growth Factor Receptor, the Fibroblast Growth Factor Receptor, and Src Family Tyrosine Kinases,” Pharmacol. Ther., vol. 76, No. 1-3, pp. 55-71 (1997).
Myllärniemi Marjukka et al., “Selective Tyrosine Kinase Inhibitor for the Platelet-Derived Growth Factor Receptor In Vitro Inhibits Smooth Muscle Cell Proliferation After Reinjury of Arterial Intima In Vivo, ” Cardiovascular Drugs and Therapy, vol. 13, pp. 159-168 (1999).
Radebough, Galen W., “Preformulation, ” Remington: The Science and Practice of Pharmacy, 20th Edition, Chapter 83, pp. 1447-1462 (2000).

Affiliated with

Also associated with

Rating

Crystal modification of a N-phenyl-2-pyrimidineamine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystal modification of a N-phenyl-2-pyrimidineamine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal modification of a N-phenyl-2-pyrimidineamine... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3460779